Aisling Capital Partners IV, LP (CIK 0001737020)

Latest company ownership

VIRX - Viracta Therapeutics, Inc.

Role: 10% Owner

Shares held

10,100,000

Last filed at

Jul 15, 2019

Confidence Score

50.0

2025Q4

Confidence Score History

2019Q3 2025Q4

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Jul 15, 2019	Jul 15, 2019	Viracta Therapeutics, Inc.	10% Owner	Buy	100.0	+2,500,000	32.89%	✗	$1.5M